Skip to contentB
Biogen Inc.
B
BIIBBiogen Inc. Q1 2014 · 10-Q
Revenue$2.13B$2.13B+50.5% vs Q1 2013 Net Income$480.00M$480.00M+12.5% vs Q1 2013 EPS Diluted$2.02$2.02+12.8% vs Q1 2013 Gross Profit$1,850,500,000+44.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biogen Inc. · CIK 875045 · Engraved from SEC EDGAR
Operating Cash Flow$104,626,000−41.5% Free Cash Flowderived$50,320,000−65.5% Margins · derivedGross margin86.9%−3.7 pt vs Q1 2013
Operating margin31.5%−4.6 pt vs Q1 2013
Net margin22.5%−7.6 pt vs Q1 2013
ended Mar 31, 2014 · filed Apr 23, 2014 · 23 d after period end